Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke

Journal of Neuroimmune Pharmacology

Volumn 4, Issue 2, 2009, Pages 249-259

  Zhang, Ming ^a   Martin, Billy R ^b   Adler, Martin W ^a   Razdan, Raj J ^c   Kong, Weimin ^a   Ganea, Doina ^a   Tuma, Ronald F ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ORGANIX INC   (United States)

Author keywords

CB1; CB2; EAE; Endocannabinoid system; Neuroprotection; Stroke

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOID RECEPTOR AGONIST; CYTOKINE; FATTY ACID AMIDASE INHIBITOR; O 1966; O 3853; RIMONABANT; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL INVASION; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; EXPERIMENTAL MODEL; IMMUNOCOMPETENT CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LYMPHOCYTE PROLIFERATION; MICROVASCULATURE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; STROKE; T LYMPHOCYTE;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; NEUROPROTECTIVE AGENTS; RECEPTORS, CANNABINOID; STROKE;

EID: 67649101330     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-009-9148-4     Document Type: Review

References (66)

1. AS Archambault J Sim 2005 Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma Eur J Immunol 35 4 1076 1085 (Pubitemid 40542214)
2. JC Ashton RM Rahman 2007 Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain Neurosci Lett 412 2 114 117 (Pubitemid 46074356)
3. D Baker G Pryce 2000 Cannabinoids control spasticity and tremor in a multiple sclerosis model Nature 404 6773 84 87 (Pubitemid 30143137)
4. D Baker G Pryce 2001 Endocannabinoids control spasticity in a multiple sclerosis model FASEB J 15 2 300 302
5. S Batkai D Osei-Hyiaman 2007 Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury FASEB J 21 8 1788 1800 (Pubitemid 46855625)
6. B Becher I Bechmann 2006 Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain J Mol Med 84 7 532 543 (Pubitemid 43992845)
7. C Berger PC Schmid 2004 Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia J Neurochem 88 5 1159 1167 (Pubitemid 38280683)
8. F Correa L Mestre 2005 Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling Br J Pharmacol 145 4 441 448 (Pubitemid 40966273)
9. DA Dawson CA Ruetzler 1996 Polymorphonuclear leukocytes and microcirculatory perfusion in acute stroke in the SHR Keio J Med 45 3 248 252 (Pubitemid 126557332)
10. BN Dittel 2008 Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor Br J Pharmacol 153 2 271 276
11. AJ Dutka JM Hallenbeck 1987 A brief episode of severe arterial hypertension induces delayed deterioration of brain function and worsens blood flow after transient multifocal cerebral ischemia Stroke 18 2 386 395 (Pubitemid 17059664)
12. AJ Dutka P Kochanek 1988 Air embolism may cause unrecognized ischemia of the gray-white junction Undersea Biomed Res 15 2 99 106 (Pubitemid 18084732)
13. AJ Dutka PM Kochanek 1989 Influence of granulocytopenia on canine cerebral ischemia induced by air embolism Stroke 20 3 390 395 (Pubitemid 19080098)
14. E Eljaschewitsch A Witting 2006 The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells Neuron 49 1 67 79 (Pubitemid 43017186)
15. SA Golech RM McCarron 2004 Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors Brain Res Mol Brain Res 132 1 87 92 (Pubitemid 39531355)
16. M Greter FL Heppner 2005 Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis Nat Med 11 3 328 334 (Pubitemid 40460562)
17. JM Hallenbeck AJ Dutka 1986 Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period Stroke 17 2 246 253 (Pubitemid 16125248)
18. JM Hallenbeck AJ Dutka 1988 Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction Stroke 19 7 863 869 (Pubitemid 18182090)
19. K Hayakawa K Mishima 2004 Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism Neuroreport 15 15 2381 2385 (Pubitemid 39488924)
20. FL Heppner M Greter 2005 Experimental autoimmune encephalomyelitis repressed by microglial paralysis Nat Med 11 2 146 152 (Pubitemid 40321349)
21. WF Hickey H Kimura 1988 Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo Science 239 4837 290 292 (Pubitemid 18061496)
22. Z Jarai JA Wagner 1999 Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc Natl Acad Sci U S A 96 24 14136 14141
23. KL Jin XO Mao 2000 CB1 cannabinoid receptor induction in experimental stroke Ann Neurol 48 2 257 261 (Pubitemid 30617047)
24. TW Klein 2005 Cannabinoid-based drugs as anti-inflammatory therapeutics Nat Rev Immunol 5 5 400 411 (Pubitemid 40685989)
25. TW Klein GA Cabral 2006 Cannabinoid-induced immune suppression and modulation of antigen-presenting cells J Neuroimmune Pharmacol 1 50 64
26. TW Klein C Newton 2004 Cannabinoid receptors and T helper cells J Neuroimmunol 147 1-2 91 94 (Pubitemid 38114954)
27. PM Kochanek JM Hallenbeck 1992 Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke Stroke 23 9 1367 1379
28. PM Kochanek AJ Dutka 1987 Indomethacin, prostacyclin, and heparin improve postischemic cerebral blood flow without affecting early postischemic granulocyte accumulation Stroke 18 3 634 637 (Pubitemid 17080580)
29. PM Kochanek AJ Dutka 1987 Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia Life Sci 41 24 2639 2644 (Pubitemid 18051586)
30. PM Kochanek AJ Dutka 1988 Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain Stroke 19 6 693 699 (Pubitemid 18152036)
31. RR Leker N Gai 2003 Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210 Stroke 34 8 2000 2006 (Pubitemid 36944797)
32. PJ Little DR Compton 1988 Pharmacology and stereoselectivity of structurally novel cannabinoids in mice J Pharmacol Exp Ther 247 3 1046 1051 (Pubitemid 19022114)
33. DF Louw FW Yang 2000 The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat Brain Res 857 1-2 183 187 (Pubitemid 30107804)
34. T Lu C Newton 2006 Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection J Pharmacol Exp Ther 319 1 269 276 (Pubitemid 44455132)
35. WD Lyman JR Sonett 1989 Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis J Neuroimmunol 23 1 73 81 (Pubitemid 19125801)
36. K Mackie 2006 Cannabinoid receptors as therapeutic targets Annu Rev Pharmacol Toxicol 46 101 122 (Pubitemid 43271185)
37. K Maresz G Pryce 2007 Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on autoreactive T cells Nat Med 13 4 492 497 (Pubitemid 46559830)
38. L McCollum AC Howlett 2007 Anandamide-mediated CB1/CB2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells J Pharmacol Exp Ther 321 3 930 937 (Pubitemid 46762688)
39. EJ McMahon SL Bailey 2005 Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis Nat Med 11 3 335 339 (Pubitemid 40460563)
40. EJ McMahon SL Bailey 2006 CNS dendritic cells: critical participants in CNS inflammation Neurochem Int 49 2 195 203 (Pubitemid 43867078)
41. R Mechoulam E Fride 1998 Endocannabinoids Eur J Pharmacol 359 1 1 18 (Pubitemid 28515716)
42. S Muthian DJ Rademacher 2004 Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia Neuroscience 129 3 743 750 (Pubitemid 39487125)
43. T Nagayama AD Sinor 1999 Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J Neurosci 19 8 2987 2995 (Pubitemid 29173995)
44. X Ni EB Geller 2004 Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model Mult Scler 10 2 158 164 (Pubitemid 38499908)
45. SE O'Sullivan DA Kendall 2004 Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA) Br J Pharmacol 141 5 803 812 (Pubitemid 38446181)
46. SE O'Sullivan DA Kendall 2004 Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries Br J Pharmacol 142 3 435 442 (Pubitemid 38869856)
47. P Pacher G Hasko 2008 Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning Br J Pharmacol 153 2 252 262
48. P Pacher S Batkai 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 3 389 462 (Pubitemid 44394908)
49. S Parmentier-Batteur K Jin 2002 Increased severity of stroke in CB1 cannabinoid receptor knock-out mice J Neurosci 22 22 9771 9775 (Pubitemid 35332860)
50. RG Pertwee 1999 Medical uses of cannabinoids: the way forward Addiction 94 3 317 320 (Pubitemid 29137412)
51. M Rajesh H Pan 2007 Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis J Leukoc Biol 82 6 1382 1389
52. V Ralevic DA Kendall 2002 Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function Life Sci 71 22 2577 2594 (Pubitemid 35282463)
53. PC Schmid RJ Krebsbach 1995 Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain FEBS Lett 375 1-2 117 120
54. B Shouman RH Fontaine 2006 Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage Br J Pharmacol 148 4 442 451 (Pubitemid 43882080)
55. C Sommer M Schomacher 2006 Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra Acta Neuropathol 112 3 277 286 (Pubitemid 44275883)
56. L Steinman 1996 Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system Cell 85 3 299 302 (Pubitemid 26160700)
57. N Stella 2004 Cannabinoid signaling in glial cells Glia 48 4 267 277 (Pubitemid 39578029)
58. M van der Stelt WB Veldhuis 2001 Neuroprotection by Delta9- tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity J Neurosci 21 17 6475 6479 (Pubitemid 32781091)
59. M van der Stelt WB Veldhuis 2001 Exogenous anandamide protects rat brain against acute neuronal injury in vivo J Neurosci 21 22 8765 8771 (Pubitemid 33054840)
60. M Weaver K Leshley 2002 LEX032, a novel recombinant serpin, protects the brain after transient focal ischemia Microvasc Res 63 3 327 334
61. JL Wiley ID Beletskaya 2002 Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists J Pharmacol Exp Ther 301 2 679 689 (Pubitemid 34429984)
62. I Wirguin R Mechoulam 1994 Suppression of experimental autoimmune encephalomyelitis by cannabinoids Immunopharmacology 28 3 209 214 (Pubitemid 24316897)
63. A Witting L Chen 2006 Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection Proc Natl Acad Sci U S A 103 16 6362 6367
64. M Yuan SM Kiertscher 2002 Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells J Neuroimmunol 133 1-2 124 131 (Pubitemid 35346734)
65. M Zhang BR Martin 2007 Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model J Cereb Blood Flow Metab 27 7 1387 1396 (Pubitemid 46985356)
66. M Zhang BR Martin 2008 Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury Neuroscience 152 3 753 760 (Pubitemid 350235710)